PDLIM7 and nasopharyngeal carcinoma: Therefore, Yang et al. 69 successfully obtained a phosphorothioate-modified “10-23” DNAzyme, named DZ1, which could downregulate the expression of LMP1 in NPC cells, to explore the potential use of DNAzymes for the new treatment of NPC.